AlphaYou
Overview
8 funds hold it, insiders have been net selling, and 7 straight earnings beats.
Key stats
Sep 5- Open
- $96.57
- 52-wk high
- $110.00
- High
- $97.69
- 52-wk low
- $67.46
- Low
- $96.29
- Prev close
- $97.20
- Mkt cap
- $124.32B
- P/E
- 25.6x
- Volume
- 4.48M
- Fwd P/E
- 11.5x
- Beta
- 0.60
- Div yield
- 2.74%
- P/S
- 0.3x
- P/B
- 1.6x
- Profit margin
- +1.2%
- Op margin
- +3.9%
- ROE
- +6.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 38.0% above what analysts expected.
Earnings per share
$1.87 expected
GAAP EPS was $2.31 and adjusted EPS was $2.58. The analyst basis could not be confirmed, so no beat or miss is shown.
What the street expects next
EPS expected
$1.46 to $1.82
Revenue expected
16 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $102.87B | $105.69B | $100.43B | $106.10B |
| Cost of what it sold | $89.06B | $92.13B | $84.80B | $90.35B |
| Gross profit | $13.81B | $13.57B | $15.62B | $15.75B |
| What it spent | ||||
| Other operating costs | $17.01B | $11.46B | $10.94B | $11.05B |
| Total operating expenses | $17.01B | $11.46B | $10.94B | $11.05B |
| What was left | ||||
| Operating profit | -$3.21B | $2.11B | $4.68B | $4.70B |
| Interest on debt | $784.0M | $787.0M | $774.0M | $757.0M |
| Profit before tax | -$3.48B | $1.35B | $3.94B | $3.98B |
| Tax | $508.0M | -$1.57B | $995.0M | $982.0M |
| Net profit | -$3.98B | $2.94B | $2.94B | $3.00B |
| EBITDA | -$1.56B | $3.29B | $5.83B | $5.86B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Arnold Craig Acquires 6,400 Shares of Honeywell Aerospace at $156 Each
NeutralSep 4Inogen Inc (NASDAQ: INGN) Grants 1,500 Shares to Chief Accounting Officer Mary E Wright at $5.33 Each
NeutralSep 4Davis John Linzy Increases Stake with 12,853 New Shares in Solidion Technology
NeutralSep 4Hoogendoorn David Holds 1,524 Derivative Securities Following Penske Automotive Group Director Award
NeutralSep 4Target to Open 8 More Stores This Fall
Leans bullishSep 4TD Waterhouse Canada Inc. Increases Stake in CVS Health Corporation $CVS
BullishSep 4Herc Holdings Extends Receivables Financing Agreement Maturity to 2027 with Increased Borrowing Capacity
NeutralSep 4Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S.
BullishSep 3
Macro
10 macro signals shaping CVS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results